[1] 夏冰,程虹.溃疡性结肠炎的生物治疗[J].临床消化病杂志,2007,19:16-19.
[2] MARTNEZ-MONTIEL M P,MUNOZ-YAGE M T.Biologic Therapies for Chronic Inflammatory Bowel Disease[J].Revista Espanola de Enfermedades Digestivas,2006,98:265-291.
[3] 郑虎占.中药现代研究与应用[M].2版.北京:学苑出版社,1997:10.
[4] 陈雄.甘草酸二铵注射液对大鼠肾缺血/再灌注损伤的保护作用[J].时珍国医国药,2007,18(9):2197-2198.
[5] 杨丽蓉,徐晓玉.甘利欣的药理作用与临床应用[J].中国医院用药评价与分析,2003,3(3):191-192.
[6] 王雅丽,李亮成,徐大毅,等.甘草酸二铵替代激素治疗大鼠溃疡性结肠炎的疗效研究[J].中国医院药学杂志,2009,29(1):46-48.
[7] MURANO M,MAEMURA K,HIRATA I,et al.Therapeutic Effect of Intracolonically Administered Nuclear Factor κB (p65) Antisense Oligonucleotide on Mouse Dextran Sulphate Sodium (DSS)-Induced Colitis[J].Clinical and Experimental Immunology,2000,120(1):51-58.
[8] 黄超,邓长生.大鼠溃疡性结肠炎模型肠组织中MIF的表达和NF-κB的激活[J].世界华人消化杂志,2006,14(6):621-625.
[9] KORNBLUTH ASHER,SACHAR DAVID B.Ulcerative Colitis Practice Guidelines in Adults:American College of Gastroenterology,Practice Parameters Committee[J].American Journal of Gastroenterology,2010,105:501-523.
[10] EADEN J,ABRAMS K,EKBOM A,et al.Colorectal Cancer Prevention in Ulcerative Colitis:A Case-Control Study[J].Alimentary Pharmacology & Therapeutics,2000,14:145-153.
[11] RUSSEL M G V M.Changes in the Incidence of Inflammatory Bowel Disease:What Does It Mean? [J].European Journal of Internal Medicine,2000,11:191-196.
[12] JIANG Xueliang,CUI Huifei.An Analysis of 10218 Ulcerative Colitis Cases in China[J].World Journal of Gastroenterology,2002,8(1):158-161.
[13] DANESE SILVIO,FIOCCHI CLAUDIO.Etiopathogenesis of Inflammatory Bowel Diseases[J].World Journal of Gastroenterology,2006,12(30):4807-4812.
[14] 范恒,李小慧,段雪云,等.细胞凋亡与UC的发生[J].中国中西医结合消化杂志,2002,10(3):189-190.
[15] 张文俊,李兆申,许国铭,等.细胞凋亡调控蛋白Bcl-2和Bax在溃疡性结肠炎表达中的研究[J].中华消化内镜杂志,2003,20(4):262-264.
[16] VAN DYKE T E,SERHAN C N.Resolution of Inflammation:A New Paradigm for the Pathogenesis of Periodontal Diseases[J].Journal of Dental Research,2003,82(2):82-90.
[17] MLLER GNTER,ERTL JOHANN,GERL MARTIN,et al.Leptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes[J].Journal of Biological Chemistry,1997,272:10585-10592.
[18] LETVA FRANCISCO,GODSLAND IAN F,CHATEI MOHAMMED,et al.Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk[J].Arteriosclerosis Thrombosis and Vascular Biology,1998,18(6):928-933.
[19] MALLOLAS J,ESTEVE M,RIUS E,et al.Antineutrophil Antibodies Associated with Ulcerative Colitis Interact with the Antigen(s) During the Process of Apoptosis[J].Gut,2000,47(1):74-78.
[20] 唐湘涓,徐军发,祝斌,等.溃疡性结肠炎患者外周血中性粒细胞凋亡与细胞因子、粘附分子水平的关系[J].陕西医学杂志,2004,33(12):1069-1071.
[21] IWAMOTO MICHIKO,KOJI TAKEHIKO,MAKIYAMA KAZUYA,et al.Apoptosis of Crypt Epithelial Cells in Ulcerative Colitis[J].Journal of Pathology,1996,180(2):152-159.
[22] UEYAMA H,KIYOHARA T,SAWADA N,et al.High Fas Ligand Expression on Lymphocytes in Lesions of Ulcerative Colitis[J].Gut,1998,43(1):48-55.
[23] BOIRIVANT MONICA,MARINI MARCO,DI FELICE GABRIELLA,et al.Lamina Propria T Cells in Crohn’s Disease and Other Gastrointestinal Inflammation Show Defective CD2 Pathway-Induced Apoptosis[J].Gastroenterology,1999,116(3):557-565.
[24] 余保平,王伟岸.消化系统疾病免疫学[M].北京:科学出版社,2000:189-190.
|